Recent study showed that combined BET and MEK inhibition showed synergistic effect in inhibiting multiple NB cells growth and survival in vitro but the antitumor activity in vivo was limited which is possibly caused by the expression level of MYCN and other oncogenes such as NF1 (Healy et al., 2020). Here, MAP2K7 is linked to neuroblastoma.